Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making-Reference-Cited by-同舟云学术

Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making

Published:2023-03-02 Issue: Volume: Page:
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:J. Comp. Eff. Res.

Author:

Németh Bertalan¹^ORCID,Kamusheva Maria²^ORCID,Mitkova Zornitsa²^ORCID,Petykó Zsuzsanna Ida¹^ORCID,Zemplényi Antal¹³^ORCID,Dimitrova Maria²^ORCID,Tachkov Konstantin²^ORCID,Balkányi László⁴^ORCID,Czech Marcin⁵^ORCID,Dawoud Dalia⁶⁷^ORCID,Goettsch Wim⁸⁹^ORCID,Hren Rok¹⁰,Knies Saskia⁹^ORCID,Lorenzovici László¹¹¹²^ORCID,Maravic Zorana¹³^ORCID,Piniazhko Oresta¹⁴^ORCID,Zerovnik Spela¹⁵,Kaló Zoltán¹¹⁶^ORCID

Affiliation:

1. Syreon Research Institute, Budapest, HU 1142, Hungary

2. Department of Organization & Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BG 1000, Bulgaria

3. Center for Health Technology Assessment & Pharmacoeconomics Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary

4. Medical Informatics R&D Center, Pannon University, Veszprém, HU 8200, Hungary

5. Department of Pharmacoeconomics, Institute of Mother & Child, Warsaw, PL 01-211, Poland

6. Science Policy & Research Programme, Science Evidence & Analytics Directorate, National Institute for Health & Care Excellence (NICE), London, United Kingdom

7. Cairo University, Faculty of Pharmacy, Cairo, Egypt

8. Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands

9. National Health Care Institute, Diemen, NL 1120 AH, The Netherlands

10. Faculty of Mathematics & Physics, University of Ljubljana, Ljubljana, Slovenia

11. Syreon Research Romania, Tirgu Mures, RO 540004, Romania

12. G. E. Palade University of Medicine, Pharmacy, Science & Technology, Tirgu Mures, RO 540142, Romania

13. Digestive Cancers Europe, Brussels, BE 1040, Belgium

14. HTA Department of State Expert Centre of the Ministry of Health of Ukraine, Kyiv, Ukraine

15. Ministry of Health, Ljubljana, Slovenia

16. Centre for Health Technology Assessment, Semmelweis University, Budapest, HU 1091 Hungary

Abstract

Aim:Real-world data and real-world evidence (RWE) are becoming more important for healthcare decision making and health technology assessment. We aimed to propose solutions to overcome barriers preventing Central and Eastern European (CEE) countries from using RWE generated in Western Europe.Materials & methods:To achieve this, following a scoping review and a webinar, the most important barriers were selected through a survey. A workshop was held with CEE experts to discuss proposed solutions.Results:Based on survey results, we selected the nine most important barriers. Multiple solutions were proposed, for example, the need for a European consensus, and building trust in using RWE.Conclusion:Through collaboration with regional stakeholders, we proposed a list of solutions to overcome barriers on transferring RWE from Western Europe to CEE countries.

Funder

Horizon 2020 Framework Programme

Publisher

Becaris Publishing Limited

Subject

Health Policy

Reference30 articles.

1. The new definition of health technology assessment: a milestone in international collaboration;O'Rourke B;Int. J. Technol. Assess. Health Care,2020

2. The transferability of health technology assessment: the European perspective with focus on Central and Eastern European countries;Németh B;Expert Rev. Pharmacoecon. Outcomes Res.,2020

3. What is real-world data? A review of definitions based on literature and stakeholder interviews;Makady A;Value Health,2017

4. Haute Autorité de santé (HAS). Real-world studies for the assessment of medicinal products and medical devices. www.has-sante.fr/upload/docs/application/pdf/2021-06/real-world_studies_for_the_assessment_of_medicinal_products_and_medical_devices.pdf

5. US Department of Health and Human Services Food and Drug Administration (FDA). Real-world data (RWD) and real-world evidence (RWE) are playing an increasing role in health care decisions. www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transferability of new methods for health technology assessment in the field of diabetes between early and late adopters’ countries;Biotechnology & Biotechnological Equipment;2024-06-25

2. Real-world evidence in the reassessment of oncology therapies: payer perceptions from five countries;Future Oncology;2024-04-25

3. Prevalence and risk factors of burnout among community pharmacists in Northeast region of Bulgaria - a pilot study;Pharmacia;2023-10-03